Serum neurofilament light chain in hereditary transthyretin amyloidosis: validation in real-life practice.

Antonia S CarrollYousuf RazviLuke O'DonnellElena VelevaAmanda HeslegraveHenrik ZetterbergSteve VucicMatthew C KiernanAlexander M RossorJulian D GillmoreMary M Reilly

Published in: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis (2024)

This data validates the use of serum NfL to identify conversion to symptomatic disease in ATTRv-PN. NfL levels can guide assessment of disease progression and response to therapies.

Keyphrases

healthcare
primary care
electronic health record
big data
multiple myeloma